Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan.
Respir Investig
; 59(6): 819-826, 2021 Nov.
Article
in En
| MEDLINE
| ID: mdl-33994347
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridones
/
Idiopathic Pulmonary Fibrosis
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Respir Investig
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: